Long-Term Pharmacokinetics of Dalbavancin in ABSSSI and Osteoarticular Settings: A Real-Life Outpatient Context

Dalbavancin is a lipoglycopeptide approved for treatment of Gram-positive infections of skin and skin-associated structures (ABSSSI). Currently, off-label use at high dosages for osteoarticular infections deserves attention. This work aimed to study the long-term plasma pharmacokinetics of dalbavanc...

Descripción completa

Detalles Bibliográficos
Autores principales: De Nicolò, Amedeo, Stroffolini, Giacomo, Antonucci, Miriam, Mula, Jacopo, De Vivo, Elisa Delia, Cusato, Jessica, Palermiti, Alice, Cariti, Giuseppe, Di Perri, Giovanni, Corcione, Silvia, De Rosa, Francesco Giuseppe, D’Avolio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533485/
https://www.ncbi.nlm.nih.gov/pubmed/34680409
http://dx.doi.org/10.3390/biomedicines9101288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533485/
https://www.ncbi.nlm.nih.gov/pubmed/34680409
http://dx.doi.org/10.3390/biomedicines9101288

Ejemplares similares